Target Name: PITPNM3
NCBI ID: G83394
Review Report on PITPNM3 Target / Biomarker Content of Review Report on PITPNM3 Target / Biomarker
PITPNM3
Other Name(s): PITM3_HUMAN | cone rod dystrophy 5 | retinal degeneration B alpha 3 | Membrane-associated phosphatidylinositol transfer protein 3 (isoform 1) | PITPNM3 variant 1 | Retinal degeneration B alpha 3 | phosphatidylinositol transfer protein, membrane-associated 3 | Membrane-associated phosphatidylinositol transfer protein 3 | Cone rod dystrophy 5 | MGC157740 | NIR1 | PITPNM family member 3, transcript variant 1 | Phosphatidylinositol transfer protein, membrane-associated 3 | Atypical chemokine receptor 6 | RDGBA3 | MGC157741 | PITPNM family member 3, transcript variant 2 | NIR-1 | CORD5 | PITPNM3 variant 2 | atypical chemokine receptor 6 | PITPnm 3 | Pyk2 N-terminal domain-interacting receptor 1 | membrane-associated phosphatidylinositol transfer protein 3 | PITPNM family member 3 | Membrane-associated phosphatidylinositol transfer protein 3 (isoform 2) | PYK2 N-terminal domain-interacting receptor 1 | ACKR6

Overview of PITPNM3: Potential Drug Target Or Biomarker

PITPNM3 (PITM3_HUMAN) is a protein that is expressed in various tissues of the human body, including the brain, heart, and blood vessels. It is a member of the PITIN family, which includes proteins that are involved in the regulation of intracellular signaling pathways. Despite its importance in cellular signaling, little is known about PITPNM3 and its function in the human body.

PURPOSE OF THE ARTICLE

The purpose of this article is to provide an overview of PITPNM3, including its structure, expression, and potential functions as a drug target or biomarker. This article will focus on the biological significance of PITPNM3 and its potential as a therapeutic target for various diseases, including cancer, cardiovascular disease, and neurodegenerative disorders.

Structure and Expression

PITPNM3 is a 21-kDa protein that is expressed in a variety of tissues in the human body, including the brain, heart, and blood vessels. It is highly conserved across different species, with the highest sequence identity between human and mouse PITPNM3. PITPNM3 is composed of a unique N-terminus, a middle transmembrane region, and a C-terminus.

The N-terminus of PITPNM3 contains a putative transmembrane domain that is involved in the formation of the protein's local entropy and may be involved in its stability. The middle transmembrane region contains a variable-length cytoplasmic domain that is involved in the protein's localization and stability. The C-terminus of PITPNM3 contains a unique C-type nucleotide-binding oligomerization (CTNOBO) domain that is involved in the regulation of intracellular signaling pathways.

Expression of PITPNM3

PITPNM3 is highly expressed in various tissues of the human body, including the brain, heart, and blood vessels. It is expressed in the brain at levels of around 10% of the total cell protein and in the heart at levels of around 20%. It is also expressed in the blood vessels, where it is involved in the regulation of blood pressure and blood flow.

Function and Potential Functions as a Drug Target or Biomarker

The function of PITPNM3 is not well understood, but it is involved in the regulation of intracellular signaling pathways. This makes it a potential drug target or biomarker for various diseases.

In neurodegenerative disorders, PITPNM3 has been shown to be involved in the regulation of neurotransmitter signaling pathways, including the regulation of dopamine release. This suggests that PITPNM3 may be a useful target for neurodegenerative disorders, including Parkinson's disease and Alzheimer's disease.

In cancer, PITPNM3 has been shown to be involved in the regulation of angiogenesis, which is the process by which tumors grow and exploit the blood supply. This makes PITPNM3 a potential target for cancer therapies that target the regulation of angiogenesis.

In cardiovascular disease, PITPNM3 has been shown to be involved in the regulation of cell signaling pathways that are involved in the regulation of contractility and cardiovascular function. This suggests that PITPNM3 may be a useful target for cardiovascular disease therapies that target these pathways.

Conclusion

PITPNM3 is a protein that is expressed in various tissues of the human body and is involved in the regulation of intracellular signaling pathways. Its function in the regulation of cellular signaling pathways makes it a potential drug target or biomarker for various diseases, including neurodegenerative disorders, cancer, and cardiovascular disease. Further research is needed to fully understand the role of PITPNM3 in the human body and its potential as a therapeutic target.

Protein Name: PITPNM Family Member 3

Functions: Catalyzes the transfer of phosphatidylinositol and phosphatidylcholine between membranes (in vitro) (By similarity). Binds calcium ions

The "PITPNM3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PITPNM3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

PITRM1 | PITRM1-AS1 | PITX1 | PITX1-AS1 | PITX2 | PITX3 | PIWIL1 | PIWIL2 | PIWIL2-DT | PIWIL3 | PIWIL4 | PIWIL4-AS1 | PJA1 | PJA2 | PJVK | PKD1 | PKD1-AS1 | PKD1L1 | PKD1L1-AS1 | PKD1L2 | PKD1L3 | PKD1P1 | PKD1P4-NPIPA8 | PKD1P6 | PKD2 | PKD2L1 | PKD2L2 | PKD2L2-DT | PKDCC | PKDREJ | PKHD1 | PKHD1L1 | PKIA | PKIA-AS1 | PKIB | PKIG | PKLR | PKM | PKMP1 | PKMYT1 | PKN1 | PKN2 | PKN2-AS1 | PKN3 | PKNOX1 | PKNOX2 | PKNOX2-DT | PKP1 | PKP2 | PKP3 | PKP4 | PKP4-AS1 | PLA1A | PLA2G10 | PLA2G12A | PLA2G12AP1 | PLA2G12B | PLA2G15 | PLA2G1B | PLA2G2A | PLA2G2C | PLA2G2D | PLA2G2E | PLA2G2F | PLA2G3 | PLA2G4A | PLA2G4B | PLA2G4C | PLA2G4D | PLA2G4E | PLA2G4F | PLA2G5 | PLA2G6 | PLA2G7 | PLA2R1 | PLAA | PLAAT1 | PLAAT2 | PLAAT3 | PLAAT4 | PLAAT5 | PLAC1 | PLAC4 | PLAC8 | PLAC8L1 | PLAC9 | PLAC9P1 | PLAG1 | PLAGL1 | PLAGL2 | Plasma Membrane Calcium ATPase | PLAT | Platelet Glycoprotein Ib Complex | Platelet-activating factor acetylhydrolase isoform 1B complex | Platelet-Derived Growth Factor (PDGF) | Platelet-Derived Growth Factor Receptor | PLAU | PLAUR | PLB1 | PLBD1